- Home
- XMTR vs DYN Comparison
XMTR vs DYN Comparison
Compare XMTR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XMTR | DYN |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XMTR | DYN |
|---|---|---|
| Price | $61.42 | $19.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | ★ $53.80 | $40.00 |
| AVG Volume (30 Days) | 714.9K | ★ 3.5M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $642,780,000.00 | N/A |
| Revenue This Year | $26.71 | N/A |
| Revenue Next Year | $20.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.40 | N/A |
| 52 Week Low | $18.59 | $6.36 |
| 52 Week High | $69.26 | $26.22 |
Technical Indicators
Market Signals| Indicator | XMTR | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 56.77 | 51.00 |
| Support Level | $58.51 | $18.43 |
| Resistance Level | $64.98 | $19.86 |
| Average True Range (ATR) | 3.32 | 1.42 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 63.02 | 29.60 |
Price Performance
Historical ComparisonAbout XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.